Phase 1: The E-Governance Thesis & Systems Integration Moat

For institutional desks actively curating the latest ipo information across large-scale digital public infrastructure, health-tech architectures, and mission-critical systems integration, Bengaluru-headquartered SRIT India Limited represents an established enterprise digital transformation play. Operating with a 26-year delivery track record, the enterprise conceptualizes, engineers, and operates integrated digital platforms across healthcare IT, e-governance solutions, and optical-fibre telecommunications networks. Having executed more than 103 enterprise and sovereign projects with an aggregate historical value exceeding ₹1,234 crore, the company enters the capital markets backed by an active unexecuted order book of ₹1,182.80 crore across 102 ongoing contracts. Accessing public equity via a ₹218.40 crore mainboard BSE NSE IPO, the offering is structured cleanly as a 100% fresh issuance of 1.68 crore equity shares at the upper price band of ₹130 per share (face value ₹5), introducing zero secondary Offer for Sale (OFS) dilution.

Phase 2: Financial Forensics & Working Capital Infusion

Evaluating exactly what investors gain at the upper ₹130 price ceiling requires auditing the company’s operating cash flow against public-sector procurement cycles. Revenue from operations maintained consistent momentum, expanding to ₹450.00 crore in FY2026 from ₹389.35 crore in FY2025 and ₹271.09 crore in FY2024. Operating EBITDA printed at ₹64.77 crore (delivering a solid 14.39% margin), while Profit After Tax (PAT) expanded 28.8% to ₹43.29 crore. The balance sheet reflects conservative leverage, maintaining total debt of just ₹44.50 crore against a net worth of ₹193.27 crore (debt-to-equity ratio of 0.23x), driving a Return on Net Worth (RoNW) of 30.23% and a Return on Capital Employed (ROCE) of 28.79%. At ₹130, the issue is valued at a post-IPO P/E multiple of approximately 19.29x (and 14.25x pre-issue), pricing at an attractive entry valuation relative to peers like RailTel (24.03x) and Protean eGov Technologies (19.80x).

Management has established a disciplined deployment roadmap for the ₹218.40 crore gross proceeds:

  • ₹124.00 crore is earmarked directly to fund working capital requirements, financing execution cycles for multi-year state-level digital infrastructure and healthcare contracts.
  • ₹12.86 crore is dedicated to capital expenditure toward modernizing proprietary software platforms and technology product redevelopment.
  • The residual balance is ring-fenced for inorganic growth through strategic acquisitions and general corporate operational purposes.

Phase 3: Final Day Telemetry & Heavy Order Book Pacing

Unlike SME offerings governed by restrictive capital bars, this mainboard issuance provides broad retail accessibility. The base application lot is 115 shares, requiring an upfront cash commitment of ₹14,950 at the ₹130 cap.

Monitoring real-time order flow across the live ipo dashboard as the issue wraps up its final day of bidding today, Wednesday, September 30, 2026, the updated SRIT India subscription status reveals explosive, broad-based institutional and non-institutional absorption. Aggregate coverage surged past 59x by afternoon trade, driven by intense HNI syndication with the non-institutional (NII) book oversubscribing beyond 180x (led by bHNIs past 203x). The retail individual investor (RII) portion crossed 37x coverage, while Qualified Institutional Buyers (QIBs) deployed substantial block bids heading into the 5:00 PM close. With over 17 lakh retail applications competing for 51,130 base allotment allotments, retail applicants face an intensely competitive computerized lottery draw.

Phase 4: Shadow Market Reality & The ~28% Premium

Away from regulated exchange terminals, parallel off-market secondary dealing desks are pricing this digital infrastructure player with aggressive, high-conviction demand:

  • Dealing desks establishing the baseline ipo gmp report heightened bid intensity tracking the 100% fresh issue structure, 30.23% RoNW, and ₹1,182 crore order visibility.
  • Syndicate desks analyzing the ipo gmp live stream emphasize that unlisted allocators view the ₹124 crore working capital infusion as an immediate catalyst to accelerate billing cycles on state health mandates.
  • Mapped against the broader upcoming ipo gmp matrix, this enterprise software counter displays strong pricing resilience.
  • With the gmp today holding steady near +₹35 to +₹37 per share over the ₹130 cap, the unofficial grey market premium indicates an expected opening print around ₹165 to ₹167.
  • Dissecting the exact ipo grey market premium today translates to an implied listing markup of approximately 26.92% to 28.46%.
  • Within the deep liquidity of the mainboard ipo gmp universe, a solid ~28% gmp ipo spread provides an attractive buffer for listing day allocators.
  • If you watch this counter into listing day, secondary price discovery will depend on institutional delivery volumes and execution timelines on public-sector receivables.

Phase 5: Clearing Protocol & Settlement Timeline

The public bidding window officially concludes today, Wednesday, September 30, 2026, at the 5:00 PM UPI cutoff. Following the close, backend clearing operations immediately transition to administrative verification. Processing and auditing for this centralized bid ledger are managed directly by the designated KFin Technologies registrar team.

The critical basis of allocation algorithms will execute tomorrow, Thursday, October 1, 2026. Applicants can verify their base lot Allotment via the registrar portal using their PAN, Application Number, or Demat Client ID. Electronic unblocking of UPI mandates and direct bank refunds will process on Monday, October 5, 2026, alongside demat share credits, clearing the runway for the official secondary market debut on BSE and NSE on Tuesday, October 6, 2026.